Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Arrivo BioVentures LLC has raised $45.3M in total funding. The most recent round was Series B. The last funding was announced in November 2023.
Arrivo BioVentures LLC's investors include Jazz Pharmaceuticals, Solas BioVentures, Rex Health Ventures, Orlando Health Ventures.
Arrivo BioVentures LLC is headquartered in Morrisville, United States.
Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Arrivo BioVentures LLC is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arrivo BioVentures LLC — Funding & Investors." VCBacked, November 29, 2023, https://www.vcbacked.co/company/arrivo-bioventures-llc. Accessed October 30, 2026.
VCBacked. (2023). Arrivo BioVentures LLC — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/arrivo-bioventures-llc
{{cite web |title=Arrivo BioVentures LLC — Funding & Investors |url=https://www.vcbacked.co/company/arrivo-bioventures-llc |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated